Traditional Chinese medicine and lung cancer--From theory to practice.
💡 한 문장 핵심
전통중의학과 폐암 - 이론에서 실제까지.
5/5 보강
TL;DR
The latest progress of TCM in lung cancer which is mainly non-small cell lung cancer (NSCLC) from theory to clinical practice is summarized to carry forward the sophisticated TCM and promote the development of modern medicine.
📑 코퍼스 인용 관계
· 인용됨 4
📑 인용한 논문 (4) ▾
- Ponicidin Inhibits Lung Cancer Progression Through Coordinated Downregulation of Sulfhydry… Antioxidants (Basel, Switzerland) · 2026
- SOHLH2-RAD54L axis induces radioresistance by promoting homologous recombination repair in… Cell death discovery · 2026
- Anti-angiogenesis effect of Baiying Juhua Decoction on the non-small cell lung cancer: int… Bioresources and bioprocessing · 2026
- Phytochemical characterization and multi-target mechanism of Gleditsia sinensis Fructus in… Naunyn-Schmiedeberg's archives of pharmacology · 2026
연도별 인용 (2021–2026) · 합계 274
OpenAlex 토픽 ·
Lung Cancer Treatments and Mutations
Mycobacterium research and diagnosis
Lung Cancer Research Studies
🇰🇷 한글 요약 🌐 Abstract
【연구 목적】
전통중의학(TCM, traditional Chinese medicine)이 폐암, 특히 비소세포폐암(NSCLC, non-small cell lung cancer) 치료에서 갖는 최신 진전을 이론에서 임상 실제까지 종합적으로 정리하는 것을 목적으로 한 종설(review)입니다.
【방법】
원저 연구가 아닌 문헌 고찰(narrative review)로, 수술·방사선·항암화학·표적치료·면역치료 등 표준치료와 대비하여 TCM의 이론적 배경 및 임상 적용 근거를 요약·정리했습니다.
【주요 결과】
표준치료(특히 면역치료)가 폐암 예후를 크게 개선해 온 반면, TCM은 폐암 영역에서 체계적 근거 정리가 부족했음을 지적하며, NSCLC를 중심으로 TCM의 이론과 임상 활용 가능성을 정리·제시했습니다. (구체적 정량 효과나 생존율 데이터는 초록에 제시되지 않음)
【임상적 시사점 (성형외과 의사 관점)】
폐암·NSCLC를 다룬 종양학 종설로 성형외과 임상과 직접적 연관성은 낮습니다. 다만 전통의학(보완대체요법)을 표준치료의 근거 수준과 구분해 환자에게 설명할 때 참고할 수 있으며, 환자가 한약·보조요법 병용을 문의할 경우 근거 부족 영역임을 안내하는 데 활용 가능합니다.
With the continuous breakthroughs in molecular biology and biochemistry, we have constantly made great progress in the treatment of lung cancer. There is no doubt that standard treatment (such as surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy) has greatly improved the prognosis of lung cancer populations. In particular, the immunotherapy has brought more and more good news to countless lung cancer patients. In contrast to these standard treatments, traditional Chinese medicine (TCM) rarely has a profound and comprehensive overview in the field of lung cancer. This article will summarize the latest progress of TCM in lung cancer which is mainly non-small cell lung cancer (NSCLC) from theory to clinical practice, which would carry forward the sophisticated TCM and promote the development of modern medicine.
【연구 목적】 전통중의학(TCM, traditional Chinese medicine)이 폐암, 특히 비소세포폐암(NSCLC, non-small cell lung cancer) 치료에서 갖는 최신 진전을 이론에서 임상 실제까지 종합적으로 정리하는 것을 목적으로 한 종설(review)입니다.
APA 7
Li, Z., Feiyue, Z., & Gaofeng, L. (2021). Traditional chinese medicine and lung cancer--from theory to practice.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 137, 111381. https://doi.org/10.1016/j.biopha.2021.111381
Vancouver
Li Z, Feiyue Z, Gaofeng L. Traditional Chinese medicine and lung cancer--From theory to practice. Biom. & phar. = Biom. & phar.. 2021;137:111381. doi:10.1016/j.biopha.2021.111381
AMA 11
Li Z, Feiyue Z, Gaofeng L. Traditional Chinese medicine and lung cancer--From theory to practice. Biom. & phar. = Biom. & phar.. 2021;137:111381. doi:10.1016/j.biopha.2021.111381
Chicago
Li, Z., Feiyue, Z., and Gaofeng, L.. 2021. "Traditional Chinese medicine and lung cancer--From theory to practice." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 137: 111381. https://doi.org/10.1016/j.biopha.2021.111381
MLA 9
Li, Z., et al. "Traditional Chinese medicine and lung cancer--From theory to practice." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 137, 2021, pp. 111381. doi:10.1016/j.biopha.2021.111381.
PMID
33601147 ↗
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 약물 | TCM
→ traditional Chinese medicine
|
전통중의학(TCM) | scispacy | 1 | |
| 질환 | lung cancer
|
폐암 | scispacy | 1 | |
| 질환 | TCM
→ traditional Chinese medicine
|
전통중의학(TCM) | scispacy | 1 | |
| 질환 | non-small cell lung cancer
|
scispacy | 1 | ||
| 질환 | NSCLC
→ non-small cell lung cancer
|
scispacy | 1 | ||
| 질환 | lung cancer patients
|
scispacy | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
그래프 OA 노드: 3/4 (75%)
· 참조 0편 · 후속 3편
이 논문을 인용한 후속 연구 4
- Phytochemical characterization and multi-target mechanism of Gleditsia sinensis Fructus in lung aden…
- Anti-angiogenesis effect of Baiying Juhua Decoction on the non-small cell lung cancer: integrating p…
- SOHLH2-RAD54L axis induces radioresistance by promoting homologous recombination repair in non-small…
- Ponicidin Inhibits Lung Cancer Progression Through Coordinated Downregulation of Sulfhydryl Antioxid…
같은 제1저자의 인용 많은 논문 (5)
- Protopanaxatirol type ginsenoside Re promotes cyclic growth of hair follicles via inhibiting transforming growth factor β signaling cascades.
- Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling.
- CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGFβ/IGF1 signaling in gastric Cancer.
- Efficacy and safety of robotic vs. laparoscopic gastrectomy for patients with gastric cancer: systematic review and meta-analysis.
- Garsorasib in patients with KRAS-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial.